​

scPharmaceuticals (SCPH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SCPH Stock Forecast

scPharmaceuticals (SCPH) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $5.68, with a high of $6.00 and a low of $5.35. This represents a 0.18% increase from the last price of $5.67.

High: $6 Avg: $5.68 Low: $5.35 Last Closed Price: $5.67

SCPH Stock Rating

scPharmaceuticals stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 3 5 Strong Sell Sell Hold Buy Strong Buy

SCPH Price Target Upside V Benchmarks

TypeNameUpside
StockscPharmaceuticals0.18%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-23
Avg Price Target-$5.68$8.12
Last Closing Price$5.67$5.67$5.67
Upside/Downside-0.18%43.21%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-13--4
Sep, 25-13--4
Aug, 2523---5
Jul, 2523---5
Jun, 2524---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 29, 2025H.C. Wainwright$5.35$5.50-2.73%-5.64%
Aug 25, 2025Craig-Hallum$6.00$5.528.70%5.82%
Dec 02, 2024Glen SantangeloJefferies$13.00$3.81241.21%129.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 29, 2025H.C. WainwrightNeutraldowngrade
Aug 25, 2025Craig-HallumHolddowngrade
Dec 02, 2024JefferiesBuyBuyhold
Oct 23, 2024Cowen & Co.BuyBuyhold
Oct 11, 2022SVB LeerinkOutperformupgrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.42$-1.91----
Avg Forecast$-1.49$-1.81$-0.94$0.27$1.34$1.94
High Forecast$-1.37$-1.73$-0.72$1.19$2.06$2.32
Low Forecast$-1.56$-1.93$-1.13$-0.29$0.20$1.67
Surprise %-4.70%5.52%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.59M$36.33M----
Avg Forecast$13.02M$36.28M$84.08M$167.31M$249.68M$283.45M
High Forecast$15.00M$36.54M$97.41M$167.31M$287.74M$326.66M
Low Forecast$11.63M$36.09M$76.21M$167.31M$223.00M$253.17M
Surprise %4.40%0.14%----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-54.81M$-85.15M----
Avg Forecast$-54.81M$-70.44M$-35.77M$13.59M$70.91M$74.72M
High Forecast$-52.65M$-66.58M$-27.88M$45.73M$79.34M$89.52M
Low Forecast$-60.23M$-74.31M$-43.67M$-11.14M$7.70M$64.34M
Surprise %-20.87%----

SCPH Forecast FAQ

Is scPharmaceuticals stock a buy?

scPharmaceuticals stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that scPharmaceuticals is a favorable investment for most analysts.

What is scPharmaceuticals's price target?

scPharmaceuticals's price target, set by 8 Wall Street analysts, averages $5.68 over the next 12 months. The price target range spans from $5.35 at the low end to $6 at the high end, suggesting a potential 0.18% change from the previous closing price of $5.67.

How does scPharmaceuticals stock forecast compare to its benchmarks?

scPharmaceuticals's stock forecast shows a 0.18% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for scPharmaceuticals over the past three months?

  • October 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is scPharmaceuticals’s EPS forecast?

scPharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.94, marking a -50.79% decrease from the reported $-1.91 in 2024. Estimates for the following years are $0.27 in 2026, $1.34 in 2027, and $1.94 in 2028.

What is scPharmaceuticals’s revenue forecast?

scPharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $84.08M, reflecting a 131.43% increase from the reported $36.33M in 2024. The forecast for 2026 is $167.31M, followed by $249.68M for 2027, and $283.45M for 2028.

What is scPharmaceuticals’s net income forecast?

scPharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-35.772M, representing a -57.99% decrease from the reported $-85.148M in 2024. Projections indicate $13.58M in 2026, $70.91M in 2027, and $74.72M in 2028.